CN103478738B - A kind of composition with fat-reducing body shaping and Weight management effect - Google Patents
A kind of composition with fat-reducing body shaping and Weight management effect Download PDFInfo
- Publication number
- CN103478738B CN103478738B CN201310426107.8A CN201310426107A CN103478738B CN 103478738 B CN103478738 B CN 103478738B CN 201310426107 A CN201310426107 A CN 201310426107A CN 103478738 B CN103478738 B CN 103478738B
- Authority
- CN
- China
- Prior art keywords
- composition
- water
- fat
- navy bean
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 110
- 230000000694 effects Effects 0.000 title claims abstract description 60
- 238000007493 shaping process Methods 0.000 title claims abstract description 16
- 230000037221 weight management Effects 0.000 title claims abstract description 14
- 244000013123 dwarf bean Species 0.000 claims abstract description 80
- 235000021278 navy bean Nutrition 0.000 claims abstract description 80
- 229940069765 bean extract Drugs 0.000 claims abstract description 66
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 45
- 239000000284 extract Substances 0.000 claims abstract description 40
- 235000021028 berry Nutrition 0.000 claims abstract description 29
- 239000008280 blood Substances 0.000 claims abstract description 11
- 210000004369 blood Anatomy 0.000 claims abstract description 11
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims description 37
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 34
- 239000007787 solid Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 23
- 235000013361 beverage Nutrition 0.000 claims description 19
- 240000008042 Zea mays Species 0.000 claims description 17
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 17
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 11
- 239000012535 impurity Substances 0.000 claims description 11
- 235000015099 wheat brans Nutrition 0.000 claims description 11
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 8
- 235000009973 maize Nutrition 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 235000016213 coffee Nutrition 0.000 claims description 5
- 235000013353 coffee beverage Nutrition 0.000 claims description 5
- -1 electuary Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 3
- 235000015203 fruit juice Nutrition 0.000 claims description 3
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 238000010348 incorporation Methods 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 12
- 210000000577 adipose tissue Anatomy 0.000 abstract description 11
- 230000009286 beneficial effect Effects 0.000 abstract description 10
- 230000000968 intestinal effect Effects 0.000 abstract description 9
- 210000003205 muscle Anatomy 0.000 abstract description 7
- 201000001421 hyperglycemia Diseases 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 abstract description 3
- 238000009395 breeding Methods 0.000 abstract description 2
- 230000001488 breeding effect Effects 0.000 abstract description 2
- 230000029142 excretion Effects 0.000 abstract description 2
- 230000002503 metabolic effect Effects 0.000 abstract description 2
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 32
- 239000003925 fat Substances 0.000 description 26
- 239000000843 powder Substances 0.000 description 22
- 239000000463 material Substances 0.000 description 20
- 238000012360 testing method Methods 0.000 description 18
- 235000013305 food Nutrition 0.000 description 17
- 238000002156 mixing Methods 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 12
- 230000037396 body weight Effects 0.000 description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 9
- 235000005822 corn Nutrition 0.000 description 9
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000003392 amylase inhibitor Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- 241001092040 Crataegus Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 244000046052 Phaseolus vulgaris Species 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 5
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 5
- 235000009685 Crataegus X maligna Nutrition 0.000 description 5
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 5
- 235000009486 Crataegus bullatus Nutrition 0.000 description 5
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 5
- 235000009682 Crataegus limnophila Nutrition 0.000 description 5
- 235000004423 Crataegus monogyna Nutrition 0.000 description 5
- 235000002313 Crataegus paludosa Nutrition 0.000 description 5
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 235000008504 concentrate Nutrition 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010033307 Overweight Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000009616 inductively coupled plasma Methods 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- 150000004823 xylans Chemical class 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000009928 pasteurization Methods 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 2
- 229960004425 sibutramine Drugs 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 229940124036 Hydrolase inhibitor Drugs 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 229940086609 Lipase inhibitor Drugs 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- DINOPBPYOCMGGD-VEDJBHDQSA-N Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 DINOPBPYOCMGGD-VEDJBHDQSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000001746 Pancreatic alpha-Amylases Human genes 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 241000219833 Phaseolus Species 0.000 description 1
- 244000045930 Phaseolus coccineus Species 0.000 description 1
- 235000010632 Phaseolus coccineus Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000019211 fat replacer Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 239000004093 hydrolase inhibitor Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000009868 osmotic diarrhea Diseases 0.000 description 1
- 208000028719 osmotic diarrheal disease Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of composition with fat-reducing body shaping and Weight management effect.Said composition forms primarily of 30% ~ 80% water-soluble dietary fiber, 5% ~ 60% navy bean extract, 5% ~ 50% oligomeric Icing Sugar and 1% ~ 20% haw berry extract by weight percentage, it is for fat or overweight and not reach fat crowd all effective, can effectively lose weight, reduce fat percentage, contribute to reducing body fat, and can significantly improve its waistline, hip circumference, strengthen muscle, improve the bodily form, make stature more have curve, and can be used for Weight management; The crowd of said composition to hyperglycaemia and high fat of blood also has auxiliary therapeutic action; All right regulating intestinal canal flora in addition, improves human body intestinal canal beneficial bacteria breeding environment, promotes vivotoxin and metabolic waste excretion, reaches the effect of toxin-expelling and face nourishing; Composition taking convenience of the present invention, meets the fast pace life requirement of modern, and safe and effective, without any side effects.
Description
Technical field
The present invention relates to a kind of composition, be specifically related to a kind of composition with fat-reducing body shaping and Weight management effect.
Background technology
Along with the development of society, the requirement of people to stature is more and more higher, fat or overweight and do not reach obese degree, has that strong desire is reduced weight, the moulding personage that likes to be beautiful can be found everywhere, and the market demand is extremely huge.The motion mode of going on a diet, can not adhere to for a long time of blindness is given on the contrary needs the people of weight reducing to bring reverse effect.The object that people are badly in need of a kind of convenience, safe and effective mode reaches body shaping and Weight management, the body shaping that current people commonly use and method for weight management mainly contain to be taken slimming medicine or diet food and wears body modelling dress etc.
At present, the slimming medicine on market has a lot, and its mode of action mainly contains appetite and controls, suppresses pipe intestinal digesting to absorb, increases energy ezpenditure etc.Appetite controlling agent can affect the nerves medium vigor, by central nervous system effect, realizes fat-reducing effect, but actual effect is limited and individual difference is larger.Suppress pipe intestinal digesting absorbent to mainly contain lipase inhibitor, glucosidase inhibitor and fat replacer, but these medicines have the gastrointestinal side effects such as certain intestinal tympanites, stomachache, diarrhoea.Increase energy ezpenditure agent can stimulate fat oxidation, increase energy ezpenditure, but patient easily produces the bad reactions such as anxiety, excitement, insomnia.
Diet food in the market comes with some shortcomings: some composition adds chemical composition in violation of rules and regulations, comprise sibutramine, phenolphthalein, melbine, insoral etc., and sibutramine is as a kind of depressor of nerve centre, may to cause elevation of the blood pressure, the serious side effects such as apocleisis, dysfunction of liver.
On the other hand, body-shaping slimming is also not equal to simple loss of weight, the weight of human body substantially by skeleton, muscle, fat and moisture four major part form, and be form by certain standard proportional, and common people too fat be because fat exceed standard, instead of due to muscle and moisture overweight.So only deduct fat, reduce the fat ratio in body weight, just can be really thin.If deducted the most muscle of health and moisture by some loss in weights, do not reach the object of fat-reducing so at all.And more seriously, if what cut is muscle and moisture, what bounce-back was returned is but fat, among that will be absorbed in and subtract more fat and more fat vicious circle.Meanwhile, due to the speed of the fat-reducing that covets, and ignore the necessary health slimming process of human body, unfavorable to health; And " bounce-back " is obvious, loses weight when taking, after withdrawing, body weight is recovered very soon; In addition, after fat-reducing, cutis laxa, wrinkle increases.
On market, another kind of body-shaping slimming mode wears body modelling dress, but the material of body modelling dress is ventilative not, affects skin perspiration, and body shaping underwear braces waist for a long time again, so easy extruding internal organs, hinders blood circulation, non-health body shaping mode.
Summary of the invention
For the problems referred to above, one object of the present invention is to provide a kind of composition.Said composition can lose weight effectively, reduce fat percentage, contribute to reducing body fat, strengthen muscle, have significant slimming effect, and intestinal beneficial flora in body can be improved, can be used for Weight management, and to the patient of hyperglycaemia, high fat of blood, there is auxiliary therapeutic action, be easy to as absorption of human body, long-term taking is without any side effects.
Another object of the present invention is to provide above-mentioned composition to have the purposes of losing weight in the composition of body shaping and Weight management effect in preparation.
Another object of the present invention is to provide above-mentioned composition preparing the purposes in the composition with hypoglycemic or reducing blood lipid auxiliary therapeutic action.
Another object of the present invention is the preparation method providing a kind of above-mentioned composition.
The object of the invention is to realize by the following technical solutions and solve.
Composition of the present invention forms primarily of 30% ~ 80% water-soluble dietary fiber, 5% ~ 60% navy bean extract, 5% ~ 50% oligomeric Icing Sugar and 1% ~ 20% haw berry extract by weight percentage.
Preferably, composition of the present invention forms primarily of 30% ~ 70% water-soluble dietary fiber, 5% ~ 50% navy bean extract, 5% ~ 20%L-arabinose, 5% ~ 50% oligomeric Icing Sugar and 1% ~ 20% haw berry extract by weight percentage.
Preferably, described oligomeric Icing Sugar is the mixture of xylo-oligosaccharide and FOS, and in described mixture, the ratio of xylo-oligosaccharide and FOS is 1:4 ~ 1:9.
Preferably, above-mentioned composition forms primarily of 40% ~ 60% water-soluble dietary fiber, 8% ~ 30% navy bean extract, 6% ~ 8%L-arabinose, 8% ~ 40% FOS, 2% ~ 5% xylo-oligosaccharide and 1% ~ 5% haw berry extract by weight percentage.
Preferably, described water-soluble dietary fiber is maize peel or wheat bran water-soluble dietary fiber.
Preferably, described water-soluble dietary fiber is maize peel water-soluble dietary fiber.
Preferably, described navy bean extract is through supercritical CO
2extract removal of impurities; Preferred employing water is as Extraction solvent, and in described navy bean extract, organic solvent-free remains;
Preferably, the AMS inhibit activities of described navy bean extract is greater than 3000AAIU/g.
Preferably, described navy bean extract is that commodity are called
product.
More preferably, described composition is by weight percentage by 50% water-soluble dietary fiber, 10% navy bean extract
8%L-arabinose, 26% FOS, 4% xylo-oligosaccharide and 2% haw berry extract form.
Preferably, the pH value of 10g dissolution of solid in 100ml water of described composition is 3 ~ 7, and preferable ph is 3-5, and more preferably pH value is 4-5; Solution temperature is 20 ~ 80 DEG C, preferably 20 ~ 60 DEG C, is more preferably 30 ~ 40 DEG C.
Composition of the present invention, can be made into various formulation and takes orally, as tablet, capsule, granule, electuary, solid beverage, oral liquid or beverage etc.
Preferably, above-mentioned composition can be made into solid beverage.Optionally, above-mentioned composition can be added in coffee or fruit juice and drink.
Composition of the present invention not only contributes to reducing body fat, effectively loses weight, and has and significantly mould waist, mould the slimming effects such as stern, for fat or overweight and not reach the crowd of obesity all effective, also can be used for support weight management.Composition of the present invention can suppress the absorption of starch in food, and then reduce the absorption of heat, reach the object reducing fat and hoard, and improve intestinal beneficial flora in body, to ensure in body shaping process without any side effects and sense of discomfort (not hungry, do not suffer from diarrhoea, not weak, not apocleisis, do not rebound, not thirsty dizziness, do not affect sleep), antiobesity action is extremely healthy gentle, is suitable for any crowd of men and women, old and young and eats.
On the other hand, present invention also offers above-mentioned composition and there is in preparation the purposes of losing weight in the composition of body shaping and Weight management effect.
On the other hand, present invention also offers above-mentioned composition and prepare the purposes in the composition with hypoglycemic or reducing blood lipid auxiliary therapeutic action.
On the other hand, the invention provides a kind of preparation method of above-mentioned composition, described composition is solid beverage, and described preparation method comprises the steps:
1) each raw material is weighed by formulation weight;
2) each raw material is crossed 30 ~ 60 mesh sieves;
3) mixed by raw material batch mixer, incorporation time is 20 ~ 40min, and rotating speed is 20 ~ 30 revs/min;
4) quantitative package.
Below respectively the function of mentioned component is discussed:
Navy bean extract: navy bean (whitekidneybeans), formal name used at school scarlet runner bean, namely Kidney bean (PhaseolusVulgarisL.), calls white waist beans etc., belongs to pulse family, Papillionoideae, Phaseoleae Phaseolus.Navy bean originates in Mexico from America and Argentina, has adapted to by artificial cultivation domestication the moist area, plateau that cools.The country that cultivated area is larger is the Britain in Argentina in America, the U.S., Mexico, Europe, the China, Japan etc. in Asia.Navy bean rich in nutritive value, containing protein 19.9% ~ 20.0% in the dry beans of every 100g, fat 1.6% ~ 2.1%, carbohydrate 37.6% ~ 48.5%, calcium 120mg, iron l0mg.In addition, also containing Cobastab
11.56mg and Cobastab
21.02mg.Now there are some researches show, the alpha-amylase inhibitor containing greater activity in navy bean, navy bean extract extracts and obtains from navy bean, and its main component is alpha-amylase inhibitor.
Alpha-amylase inhibitor (α-amylaseinhibitor is called for short α-AI) is a kind of pure-natural biological active material, belongs to the one of glycoside hydrolase inhibitor, is abroad referred to as " starchblocker ".It is the activity by suppressing ptyalin and pancreaticα-amylase, hinders starch and the digestion of other carbohydrate in enteron aisle in food, thus reduces body to the absorption of sugar.Be characterized in, excrete through intestines and stomach, therefore blood circulation system need not be entered, do not act on brain centres, not appetite-suppressing while fat-reducing, do not affect absorption and the metabolism of other nutriment such as protein, vitamin, have no side effect when using dosage is very high yet, meet the fat-reducing principle of the World Health Organization.Asian dietary structure, based on starch, is therefore started with from the activity controlling body key enzyme, selects navy bean extract to have one of principal component of the composition of body shaping and Weight management effect as the present invention.
Water-soluble dietary fiber: be a kind of high-effect dietary fiber.Its on the one hand can make people have satiety and lower appetite and reach fat-reducing effect, on the other hand can food and extend time of staying in stomach, and sugared absorbed speed is slowed down.Its major physiological function comprises: recuperating gastrointestinal tract, reduction cholesterol, suppression blood sugar raise, prevention of obesity disease.
Arabinose: its function mainly contains two aspects, one is the enzyme that can suppress to be hydrolyzed disaccharide, the blood sugar caused because taking in sucrose therefore being suppressed to raise, being called for short the blood sugar reducing function suppressing disaccharide hydrolysis; Two is because Arabinose is to the inhibitory action of disaccharide hydrolase, the sucrose be not decomposed in small intestine is decomposed by the microorganisms in large intestine and produces a large amount of organic acids, this organic acid has inhibitory action to liver synthctic fat, add Arabinose to the inhibitory action absorbing sucrose in small intestine, thus reduce the generation of new fats in body.
Oligomeric Icing Sugar: be all heavy compound sugar, can not digest and assimilate in vivo, directly large intestine is entered after edible, had inhibitory action to harmful bacteria by beneficial bacteria in large intestine utilizes, fermentation produces organic acid, synthetic vitamin simultaneously, promote mineral absorption, suppress spoilage organisms growth, stimulating animal immunity function, plays trophism by immunization route simultaneously.
Oligomeric Icing Sugar in the present invention is mainly FOS and xylo-oligosaccharide, and it directly can improve gut flora, promotes profitable strain propagation, is beneficial to host health; And the absorption of the elements such as calcium, magnesium, iron, zinc can be promoted; The hydrochloric acid in gastric juice in its not digested road and enzymic digestion, can, by the flora Bifidobacterium selective absorbing useful to human body, make the profitable strain Bifidobacterium of human body breed rapidly; Suppress the growth of pernicious bacteria simultaneously, play the effect of removing enteron aisle rubbish; Pure natural, has no side effect; In addition, suitable proportioning between FOS and xylo-oligosaccharide is selected can to reach the effect of better adjustment blood sugar and can not waste be caused.
Haw berry extract: hawthorn is the dry fruit of rosaceous plant hawthorn (RosaceaecrataegusL.), taste is sour, property is sweet, tepor, returns spleen, stomach, Liver Channel.Have food digesting stomach fortifying, promoting the circulation of qi is fallen apart effect of the stasis of blood.Hawthorn, mainly containing flavonoids, oligomeric flavanoids, organic acid and trace element, also contains the compositions such as triterpenes, steroid and organic amine in addition.The flavone compound of haw thorn extract has prevention and cure of cardiovascular disease, hemangiectasis, increase CF, improve heart vigor, stimulating central nervous system system, reduce blood pressure and cholesterol, softening blood vessel and diuresis and sedation.Often take for patients such as diabetes, coronary heart disease, hypertension, hyperlipemia, there is the effect of prevention and therapy.In addition, containing malic acid, vitamin C, citric acid and pectin in hawthorn, can prevent pigment particles from accumulating in subcutaneous, the elasticity of vascular wall can also be protected, therefore also have beauty functions to skin.
Beneficial effect of the present invention is as follows:
1. composition of the present invention is for fat or overweight and not reach fat crowd all effective, it not only can lose weight effectively, reduce fat percentage, contribute to reducing body fat, and can significantly improve its waistline, hip circumference, strengthen muscle, improve the bodily form, make stature more have curve, and can be used for Weight management.
2. the crowd of composition of the present invention to hyperglycaemia and high fat of blood also has auxiliary therapeutic action.
3. composition of the present invention, all right regulating intestinal canal flora, improves human body intestinal canal beneficial bacteria breeding environment, promotes vivotoxin and metabolic waste excretion, can reach the effect of toxin-expelling and face nourishing.
4. composition of the present invention, can be made into solid beverage, and available warm water is taken after mixing it with water, and pH value when taking is 4-5, effectively ensure that the activity of alpha-amylase inhibitor in navy bean extract.
5. composition of the present invention, can be made into solid beverage, takes very convenient, meets the fast pace life requirement of modern, and safe and effective, without any side effects.
6. composition of the present invention, preparation technology is simple, easy to operate, is applicable to industrial production.
Accompanying drawing explanation
Fig. 1 is the changes of weight situation map of laying particular stress on experimenter in clinical testing;
Fig. 2 is the fat percentage situation of change figure laying particular stress on experimenter in clinical testing;
Fig. 3 is the waistline situation of change figure laying particular stress on experimenter in clinical testing;
Fig. 4 is the hip circumference situation of change figure laying particular stress on experimenter in clinical testing;
Fig. 5 is medium body weight experimenter mean variation situation map in clinical testing;
Fig. 6 is medium body weight experimenter maximum situation of change figure in clinical testing;
The AMS inhibit activities of Fig. 7 is pH value when being 3 present composition;
The AMS inhibit activities of Fig. 8 is pH value when being 5 present composition;
The AMS inhibit activities of Fig. 9 is pH value when being 7 present composition;
Figure 10 is preparation technology's flow chart of navy bean extract in the present composition;
The production technological process that Figure 11 is the present composition when being solid beverage.
Detailed description of the invention
Further illustrate the present invention below by way of specific embodiment, but following examples are only for illustration of the present invention but not for limiting the present invention.
Experimental technique in following embodiment, if no special instructions, is conventional method.Raw material used in following embodiment, reagent material etc., if no special instructions, be commercially available purchase product.
Below respectively the preparation method of each composition of composition of the present invention is illustrated.
Navy bean extract, adopts following technique to prepare: navy bean grinds after 1.5 ~ 2.0 hours through the 1.5%NaCl water soaking of 80 DEG C, and the navy bean through grinding is by supercritical CO
2extracting removal of impurities must containing the soya-bean cake of alpha-amylase inhibitor, and soya-bean cake extracts by deionized water again, and filtration, collection filtrate, Vacuum Concentration, pasteurization, spraying dry or freeze drying obtain navy bean extract.Navy bean extract preparation technology flow chart refers to Figure 10.The quality control index of the preferred navy bean extract of the present invention is in table 1.
The quality control index of table 1 navy bean extract
Wherein:
FTIR: infrared spectrum
KarlFischer: Karl_Fischer method
ICP:InductivelyCoupledPlasma inductively coupled plasma
AA: atomic absorption spectrophotometer
AOAC: AOAC
FDA-BAM:FoodandDrugAdministration-BecteriologicalAnalyticculManual
U.S. food Drug Administration microbiological analysis handbook
Veratox:Veratox aflatoxins kit
AAIU: α-amylaseinhibitorunit, AMS inhibit activities.
Navy bean extract also can with reference to PurificationandPropertiesofPhaseolamin, anInhibitorof α-amylase, fromtheKidneyBean, Phaseolusvulgaris (J.JohnMarmen, M.Lauda, JournalofBiologicalChemistry, Vol.250, No.20, IssueofOctober25, P8030 ~ 8037,1975) preparation.Also (American-European import) navy bean extract can be bought from Shanghai Tong Yuan food technology Co., Ltd
or it is by name directly to buy commodity
navy bean extract.
Wheat bran water-soluble dietary fiber, can be prepared by following technique: wheat bran is carried out drying and processing at 60 DEG C, add the hot water (wheat: hot water=1:10) of 70 ~ 80 DEG C, add hydrochloric acid, NaOH, AMS and carbohydrase and be hydrolyzed, then wash, centrifugal dehydration, high temperature goes out enzyme (110 DEG C), dry (110 DEG C, 2h), bleaching, extrusion cooking and ultramicro grinding, obtain the wheat bran dietary fiber refined.Also can buy from French Roquette Freres.
Maize peel water-soluble dietary fiber, can be prepared by following technique: soaked by maize peel, and washing removing impurity, then adopts endogenous enzyme process to remove phytic acid (temperature 60 C, pH5.0, reaction 4h), remove starch, remove albumen, dry, pulverize, sieve, obtain maize peel water-soluble dietary fiber powder.Also can buy from Shanghai Tong Yuan food technology Co., Ltd, be the loose paddy chemical products of Japan.
Oligomeric Icing Sugar: purchased from Jiangmen Quantum High-tech Biology Co., Ltd.
FOS, can be prepared by following technique: sucrose through water-soluble solution (containing sucrose concentration: 50% ~ 60%), inject immobilization bed bioreactor inside holding (50 DEG C ~ 60 DEG C) maintenance and obtain liquid glucose in 24 hours, liquid glucose is through activated carbon decolorizing, lead to the desalination of sodium filter membrane again by ion exchange resin (liquid glucose: resin=6:1) and obtain FOS liquid, FOS liquid obtains concentrate through Vacuum Concentration, obtains FOS powder after concentrate is spray-dried.Also can buy from Jiangmen Quantum High-tech Biology Co., Ltd.
Xylo-oligosaccharide, can be prepared by following technique: pulverized by corncob and mix with water, add weak acid catalyst and carry out cracking, by the xylan stripping in corncob; The pH value regulating the xylan aqueous solution is 4.5 ~ 6.5, adds zytase and carries out enzymolysis, under the high temperature of 90 DEG C ~ 100 DEG C, carry out deactivation to zytase; Slag also discards by filtering maize cob meal, then carries out active carbon and ion exchange resin removal of impurities decolouring to xylan liquid glucose; And sodium filter membrane concentrating and desalinating; Be thick pale yellow shape syrup by xylo-oligosaccharide liquid glucose Vacuum Concentration, xylo-oligosaccharide syrup is dried to xylo-oligosaccharide powder through excipient or Direct spraying.Also can buy from Shandong Longli Biology Science and Technology Co., Ltd.
Haw berry extract, can be prepared by following technique: uctus Crataegi is dropped in extractor, add 6 times amount of medicinal material amount, 4 times of water gagings extract 2 times altogether, obtain extract, then by extract filtration, removing impurities, obtain hawthorn concentrate through concentrated, hawthorn concentrate is spray-dried obtains haw berry extract.Also can buy from flying dragon bio tech ltd, Henan.
Arabinose, can be prepared by following technique: after corncob or the bagasse through squeezing sugar being pulverized, first with hot water (70 DEG C ~ 80 DEG C) lixiviate 4 ~ 6 hours, extracting concentrate, then extracting araban through the ethanol precipitating of 75% concentration; Then the hydrochloric acid solution enzyme hydrolysis araban of 1.5% concentration is adopted to prepare Arabinose.Also can buy from Shandong Fook Tin Technologies Ltd..
The key component screening experiment of the present composition:
1. the screening of navy bean extract:
Navy bean is suitable in temperate zone and the growth of tropical high altitude localities, and property happiness is warm, not resistance to frost.Suitable geographical environmental condition makes to suppress the active constituent content of alpha-amylase activity higher in navy bean.Therefore the navy bean of our preferred original producton location north America region is main material.
The alpha-amylase inhibitor obtained in some navy bean extract, without purification, comprises toxic components (as phytolectin), impurity or pollutant.These impurity are actually solvent residue and inactive component, can cause active ingredient reduced activity.When adding in the food such as solid beverage, bland, residual impurity and pollutant easily cause disagreeable taste, make these food not cause appetite.
Therefore we are further preferably through the purer navy bean extract of purification process, preferably through supercritical CO
2extract the navy bean extract of removal of impurities; Preferred employing water is as Extraction solvent, and in navy bean extract, organic solvent-free remains.
We screen discovery further, the indexs such as the ratio of the just extraction of mark raw material and finished product on the product specification list of current some navy bean extract are on the market (as 10:1,12:1 etc.), and what really work in navy bean extract is to the inhibited composition of amylase activity, AMS suppresses the activity of composition to be applicable to AAIU(α-amylaseinhibitorunit) evaluate, lack this efficiency index of AAIU, the AMS inhibit activities of navy bean extract can be caused unstable, and the effect of such product cannot ensure.
Result shows, and the active unit of navy bean extract is for having the effect of fat-reducing body shaping more significantly by the effective guarantee present composition when being greater than 3000AAIU/g.
Therefore the active unit of further preferably navy bean extract is for being greater than 3000AAIU/g.
Further preferably, the navy bean extract that the present invention chooses is that commodity are called
navy bean (Phaseolusvulgaris) extract.
navy bean (Phaseolusvulgaris) extract is researched and developed by Pharmachem company of the U.S., is current first effective Starch blockers through complete toxicity, human clinical trial's checking in the world, and by U.S. GRAS certification.At present in the world existing 14 independently clinical report confirm
the security of product and validity.This product is the new resource food that ministry of Health of China approval in 2011 enters China's Mainland.
2. the screening of water-soluble dietary fiber:
By by 20 health adults tested corn source and wheat bran source water-soluble dietary fiber 2 weeks respectively, compare the change of capacity.
Result shows, and the people taking corn dietary fiber reacts aerogenesis hardly, and the people taking wheat bran dietary fiber reacts enteron aisle and has flatulence.Therefore, in order to be suitable for crowd widely, its work and life is not affected, the water-soluble dietary fiber of our preferred corn source.
3. the screening of compound sugar:
Different types of compound sugar, the difference of its structure, composition and glycosidic bond can be different to the suppression of the increment of beneficial bacterium in body and harmful bacteria.
We find through research, xylo-oligosaccharide, FOS and galactooligosaccharide can be utilized by beneficial bacterium (mainly Bifidobacterium and lactic acid bacteria), but galactooligosaccharide is excessive ingest after can cause what is called " osmotic diarrhea ", therefore in order to be suitable for crowd widely, our preferred FOS and xylo-oligosaccharide.Xylo-oligosaccharide and FOS by enteric bacteria utilization power in table 2.
Table 2 xylo-oligosaccharide and FOS are by enteric bacteria utilization power
| Pseudomonas | FOS | Xylo-oligosaccharide |
| Bifidobacterium adolescentis | √ | √ |
| Bifidobacterium infantis | √ | |
| Bifidobacterium longum | √ | √ |
| Bifidobacterium breve | √ | |
| Lactobacillus acidophilus | √ | |
| Saliva Bacillus acidi lactici | √ | √ |
Comprehensive xylo-oligosaccharide and FOS are by factors such as enteric bacteria utilization power and products tastes, and in our preferred composition, the proportioning of xylo-oligosaccharide and FOS is in 1:4 to 1:9 scope.
Be below specific embodiments of the invention.
embodiment 1the preparation of navy bean extract
1000g navy bean is put into grinder through the 1.5%NaCl water soaking of 80 DEG C after 1.5 ~ 2.0 hours grind, the navy bean after grinding is imported in extractor, adopt supercritical CO
2extract 3 hours at 60 DEG C, obtain the soya-bean cake containing alpha-amylase inhibitor after removal of impurities, soya-bean cake deionized water is extracted 5 hours at 50 DEG C, after filtration, collection filtrate, Vacuum Concentration, obtain navy bean extract 120g after pasteurization and spraying dry.Navy bean extract preparation technology flow chart refers to Figure 10.
Table 3 lists the testing result of the navy bean extract of above-mentioned preparation, and as seen from Table 3, the indices of the navy bean extract of preparation all meets standard-required.
The testing result of table 3 navy bean extract
The navy bean extract that the composition of following examples 2,4,7,9,11 adopts above-mentioned technique to prepare; Embodiment 3,5,6,8,10 buys (American-European import) navy bean extract from Shanghai Tong Yuan food technology Co., Ltd
embodiment 2the preparation of composition (tablet)
A kind of composition, the percentage by weight of its each component is respectively: 30% corn water-soluble dietary fiber, 5% navy bean extract, 5%L-arabinose, 45% FOS, 5% xylo-oligosaccharide and 10% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, FOS powder, navy bean extract, Arabinose, xylo-oligosaccharide powder and haw berry extract cross 30 mesh sieves, obtain mixed material after mixing 20 minutes by automatic lifting mixer under 20 revs/min.Then in mixed material, add dolomol, compressing tablet after mixing, obtains tablet.
embodiment 3the preparation of composition (capsule)
A kind of composition, the percentage by weight of its each component is respectively: 40% wheat bran water-soluble dietary fiber, 6% navy bean extract, 20%L-arabinose, 25% FOS, 5% xylo-oligosaccharide and 4% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, FOS powder, navy bean extract, Arabinose, xylo-oligosaccharide powder and haw berry extract cross 40 mesh sieves, obtain mixed material after mixing 30 minutes by automatic lifting mixer under 20 revs/min.Then in mixed material, add dolomol and starch mixing, incapsulate, obtain capsule.
embodiment 4the preparation of composition (granule)
A kind of composition, the percentage by weight of its each component is respectively: 50% wheat bran water-soluble dietary fiber, 8% navy bean extract, 7%L-arabinose, 25% FOS, 5% xylo-oligosaccharide and 5% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, FOS powder, navy bean extract, Arabinose, xylo-oligosaccharide powder and haw berry extract cross 50 mesh sieves, obtain mixed material after mixing 20 minutes by automatic lifting mixer under 30 revs/min.Then granulate with ethanol wet, wet granular is dry, and whole grain, obtains granule.
embodiment 5the preparation of composition (solid beverage)
A kind of composition, the percentage by weight of its each component is respectively: 50% corn water-soluble dietary fiber, 10% navy bean extract, 8%L-arabinose, 26% FOS, 4% xylo-oligosaccharide and 2% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, FOS powder, navy bean extract, Arabinose, xylo-oligosaccharide powder and haw berry extract cross 60 mesh sieves, obtain mixed material after mixing 30 minutes by automatic lifting mixer under 30 revs/min.Quantitative package, obtains solid beverage.The production technological process of solid beverage is shown in Figure 11.
embodiment 6the preparation of composition (electuary)
A kind of composition, the percentage by weight of its each component is respectively: 60% corn water-soluble dietary fiber, 15% navy bean extract, 9%L-arabinose, 12% FOS, 3% xylo-oligosaccharide and 1% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, FOS powder, navy bean extract, Arabinose, xylo-oligosaccharide powder and haw berry extract cross 50 mesh sieves, obtain mixed material after mixing 40 minutes by automatic lifting mixer under 20 revs/min.Quantitative package, obtains electuary.
embodiment 7the preparation of composition (oral liquid)
A kind of composition, the percentage by weight of its each component is respectively: 70% corn water-soluble dietary fiber, 10% navy bean extract, 8%L-arabinose, 8% FOS, 2% xylo-oligosaccharide and 2% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, FOS powder, navy bean extract, Arabinose, xylo-oligosaccharide powder and haw berry extract cross 60 mesh sieves, obtain mixed material after mixing 20 minutes by automatic lifting mixer under 30 revs/min.Then in mixed material, add sorbierite, purified water, heating is boiled, and stirs, and leaves standstill 24 hours, and filter, embedding becomes bottle, and sterilizing obtains oral liquid.
embodiment 8the preparation of composition (fruit drink)
A kind of composition, the percentage by weight of its each component is respectively: 80% corn water-soluble dietary fiber, 9% navy bean extract, 10% oligomeric Icing Sugar (purchased from Jiangmen Quantum High-tech Biology Co., Ltd) and 1% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, navy bean extract, oligomeric Icing Sugar and haw berry extract cross 60 mesh sieves, obtain mixed material after mixing 30 minutes by automatic lifting mixer under 30 revs/min.Quantitative package, obtains solid beverage.Optionally add in fruit juice and can obtain fruit drink.
embodiment 9the preparation of composition (chewable tablets)
A kind of composition, the percentage by weight of its each component is respectively: 30% corn water-soluble dietary fiber, 60% navy bean extract, 5% oligomeric Icing Sugar (purchased from Jiangmen Quantum High-tech Biology Co., Ltd) and 5% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, navy bean extract, oligomeric Icing Sugar and haw berry extract cross 60 mesh sieves, obtain mixed material after mixing 40 minutes by automatic lifting mixer under 20 revs/min.Then in mixed material, add dolomol, after mixing, compressing tablet obtains chewable tablets.
embodiment 10the preparation of composition (coffee solid beverage)
A kind of composition, the percentage by weight of its each component is respectively: 30% wheat bran water-soluble dietary fiber, 50% navy bean extract, 9%L-arabinose, 8% FOS, 2% xylo-oligosaccharide and 1% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, FOS powder, navy bean extract, Arabinose, xylo-oligosaccharide powder and haw berry extract cross 60 mesh sieves, obtain mixed material after mixing 30 minutes by automatic lifting mixer under 30 revs/min.Then mixed material is mixed with appropriate coffee, quantitative package, obtain containing coffee solid beverage.
embodiment 11the preparation of composition (solid beverage)
A kind of composition, the percentage by weight of its each component is respectively: 30% wheat bran water-soluble dietary fiber, 40% navy bean extract, 8% FOS, 2% xylo-oligosaccharide and 20% haw berry extract.
Preparation method: get after the water-soluble dietary fiber of recipe quantity, FOS powder, navy bean extract, xylo-oligosaccharide powder and haw berry extract cross 60 mesh sieves, obtain mixed material after mixing 30 minutes by automatic lifting mixer under 30 revs/min.Then by mixed material quantitative package, solid beverage is obtained.
embodiment 12the thermally-stabilised research of the present composition and pH screening experiment:
In order to ensure the AMS inhibit activities of product, we have carried out thermally-stabilised and pH research to composition of the present invention.
Experimental products: the 10g dissolution of solid respectively getting three parts of embodiments 5 preparations respectively, in 100ml water, measures its pH value and is about 5, and a copy of it keeps pH value to be 5, and a adjust ph is 3, and another part of adjust ph is 7, tests respectively by following condition:
Experimental technique: doelhert design matrix
Experiment condition: pH:2 ~ 7;
Temperature: 20 ~ 100 DEG C continue;
Time: 0 ~ 20min;
The AMS inhibit activities of testing product.
Testing result is shown in Fig. 7, Fig. 8 and Fig. 9; Result shows:
When pH value is 3,
1, product 20 ~ 40 DEG C, keep in 0 ~ 20min 95 ~ 100% activity;
2, temperature 20 ~ 100 DEG C, in any case heating in 0 ~ 20min, activity is all greater than 60%;
When pH value is 5,
1, product heats the activity that 10min still keeps 90 ~ 100% below 80 DEG C, highly stable; Even if heating 15 ~ 20min, still keeps the activity of 70 ~ 90%;
2, product is 90 ~ 100 DEG C of heating of Activated declines, and activity is reduced to 50 ~ 70%.
When pH value is 7,
1, product is greater than 65% the activity of 20 ~ 40 DEG C, and in 15min, the activity of 40 ~ 100 DEG C is 90 ~ 100%, more stable at 40 ~ 100 DEG C.
Therefore the pH value that 10g solid product is dissolved in 100ml water is preferably 3 ~ 7; More preferably pH value is 3 ~ 5, and further preferable ph is 4 ~ 5; Solution temperature is preferably 20 ~ 80 DEG C, preferably 20 ~ 60 DEG C, is more preferably 30 ~ 40 DEG C.
The pH value of product 10g dissolution of solid of the present invention in 100ml water is 4 ~ 5; Advise that 30 ~ 40 DEG C of warm water are taken after mixing it with water, fully can ensure the inhibit activities of its AMS.
embodiment 13fat-reducing and slimming effect test
In order to verify the beneficial effect of technical solution of the present invention further, the product of embodiment 2-11 is adopted to do following research:
One, test method
Openly collect volunteer, selection principle is the personage of the starchy food such as personage or preference bread, wheaten food, potato taking notice of body.
With 320 experimenters for subjects (comprising BMI(body-mass index), body fat, waistline the higher person), through two weeks neutral gear after dates, start to carry out to test (data are subdivided into higher (laying particular stress on) person of body fat and normal subjects (medium body reinvent body person) again, and the higher person of body fat is males fat >=20% and women's body fat >=30%).320 experimenters are divided into 10 groups, often organize 32 people (lay particular stress on woman 17 people, lay particular stress on man 9 people and medium body person 6 people that reinvents body), 10 groups of experimenters absorb 10 set products (namely each group of experimenter absorbs the product of different embodiment respectively) of embodiment 2-11 respectively, often eat and absorb product 15 ~ 20 minutes ante cibum, warm water is taken after mixing it with water, one day breakfast, lunch and dinner.Test carries out 12 weeks altogether, monthly notes down the indexs such as body weight, body fat, waistline, a hip circumference.Change relatively before and after picked-up product.
Remarks: 1. neutral gear phase and the preparatory stage, stop going on a diet, keep normal diet and movable adjustment period.
2., if tested products form is solid powder Bao Ze without the need to 20min in advance, directly take before the meal.
Two, experimenter's points for attention:
1. often eat picked-up product 15 ~ 20 minutes ante cibum (specification: 10g), coordinate one glass of warm plain boiled water or soup to take.
2. tested period dinner is tried one's best before arrangement 7 and is eaten, and does not eat food.
3. if forget before the meal and take, please at mealtime solid powder bag is opened, powder is sprinkled upon on food and uses.
If sensation is hungry after 4. taking product, more edible fresh, the low sugar fruit of suggestion, snack of trying not.
5. if coordinate appropriate motion every day during taking product, then more contribute to product and play effect.
Three, observation index
Body weight (batheroom scale), body fat (Omron body fat instrument), waistline (tape measure), hip circumference (tape measure).
Four, result
The data recorded are divided into and lay particular stress on woman's group, lay particular stress on man's group and medium body and reinvent body group and carry out statistical analysis process, before the experiment of effective (people), efficient (%), maximum wherein in statistics, average deduction item, numerical value is all set to 0, its statistics is the result of 320 people (10 groups) integration test, in table 4, table 5 and table 6, final average statistics the results are shown in Table 7, table 8 and table 9.
Table 4 is laid particular stress on woman and is organized statistics
Table 5 is laid particular stress on man and is organized statistics
Table 6 medium body reinvents body group statistics
Table 7 is laid particular stress on woman and is organized final average statistics result
Table 8 is laid particular stress on man and is organized final average statistics result
Table 9 medium body reinvents the final average statistics result of body group
Fig. 1-4 shows in clinical testing the body weight, fat percentage, waistline and the hip circumference situation of change that lay particular stress on experimenter, and Fig. 5-6 shows the situation of change of medium body weight experimenter mean value and maximum in clinical testing.Find out from table 4-9 and Fig. 1-6, totally 10 set products are efficient in body weight, fat percentage, waistline and the hip circumference statistics of 12 weeks all almost reaches 100% for embodiment of the present invention 2-11, illustrate that 10 set products all have significant fat-reducing and slimming effect.In addition, according to result of the test, in the product of embodiment 2-11, after experimenter takes the product of embodiment 5, achieve best fat-reducing and slimming effect.
To sum up, after the inclined severe one of body weight eats the technical program product for a long time, body weight obviously alleviates, and waistline and hip circumference obviously reduce, and fat percentage takes a turn for the better to some extent.And medium body severe one for a long time after edible the technical program product waistline and hip circumference also obviously reduce, make body more be added with curve.Prove that product of the present invention has significant fat-reducing and slimming effect thus, especially for minimizing waistline and hip circumference the most remarkable, and without any side effects.And a lot of experimenter reacts its skin also than originally more smooth, illustrates that the technical program product also has certain toxin-expelling and face nourishing effect.
Claims (18)
1. a composition, it is made up of 50% water-soluble dietary fiber, 10% navy bean extract, 8%L-arabinose, 26% FOS, 4% xylo-oligosaccharide and 2% haw berry extract by weight percentage.
2. composition according to claim 1, is characterized in that, described water-soluble dietary fiber is maize peel or wheat bran water-soluble dietary fiber.
3. composition according to claim 1, is characterized in that, described water-soluble dietary fiber is maize peel water-soluble dietary fiber.
4. composition according to claim 1, is characterized in that, described navy bean extract is through supercritical CO
2extract removal of impurities.
5. composition according to claim 1, is characterized in that, described navy bean extract adopts water as Extraction solvent, and in described navy bean extract, organic solvent-free remains.
6. composition according to claim 1, is characterized in that, the AMS inhibit activities of described navy bean extract is greater than 3000AAIU/g.
7. composition according to claim 1, is characterized in that, the pH value of 10g dissolution of solid in 100ml water of described composition is 3 ~ 7.
8. composition according to claim 7, is characterized in that, the pH value of 10g dissolution of solid in 100ml water of described composition is 3 ~ 5.
9. composition according to claim 7, is characterized in that, the pH value of 10g dissolution of solid in 100ml water of described composition is 4 ~ 5.
10. composition according to claim 7, is characterized in that, described solution temperature is 20 ~ 80 DEG C.
11. compositions according to claim 7, is characterized in that, described solution temperature is 20 ~ 60 DEG C.
12. compositions according to claim 7, is characterized in that, described solution temperature is 30 ~ 40 DEG C.
13. compositions according to claim 1, is characterized in that, described composition is tablet, capsule, granule, electuary, solid beverage or oral liquid.
14. compositions according to claim 1, is characterized in that, described composition is solid beverage.
15. composition according to claim 1, is characterized in that, described composition is added in coffee or fruit juice and drinks.
16. 1 kinds of compositions according to any one of claim 1 to 15 are preparing the purposes in the composition with body shaping and Weight management effect.
17. 1 kinds of compositions according to any one of claim 1 to 15 are preparing the purposes in the composition with hypoglycemic or reducing blood lipid auxiliary therapeutic action.
The preparation method of 18. 1 kinds of compositions according to any one of claim 1 to 14, described composition is solid beverage, it is characterized in that, described preparation method comprises the steps:
1) each raw material is weighed by formulation weight;
2) each raw material is crossed 30 ~ 60 mesh sieves;
3) mixed by raw material batch mixer, incorporation time is 20 ~ 40min, and rotating speed is 20 ~ 30 revs/min;
4) quantitative package.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310426107.8A CN103478738B (en) | 2013-09-17 | 2013-09-17 | A kind of composition with fat-reducing body shaping and Weight management effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310426107.8A CN103478738B (en) | 2013-09-17 | 2013-09-17 | A kind of composition with fat-reducing body shaping and Weight management effect |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103478738A CN103478738A (en) | 2014-01-01 |
| CN103478738B true CN103478738B (en) | 2016-02-10 |
Family
ID=49819600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310426107.8A Active CN103478738B (en) | 2013-09-17 | 2013-09-17 | A kind of composition with fat-reducing body shaping and Weight management effect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103478738B (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103920140B (en) * | 2014-05-04 | 2016-06-08 | 云南康洲生物科技有限公司 | A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation |
| CN104288163B (en) * | 2014-11-04 | 2017-05-10 | 广西壮族自治区中国科学院广西植物研究所 | Application of L-arabinose to preparation of medicine or health care products for preventing or curing hyperammonemia |
| CN105613651A (en) * | 2014-11-04 | 2016-06-01 | 李明贞 | Phaseolus vulgaris extract containing composition and baked food and processing method of the baked food |
| CN105661492A (en) * | 2015-12-31 | 2016-06-15 | 天津正大珍吾堂食品股份有限公司 | Full-nutrition food for controlling weight |
| CN105725191A (en) * | 2016-02-16 | 2016-07-06 | 江苏隆力奇生物科技股份有限公司 | Composition having face-beautifying and weight-losing effects and preparation method and application thereof |
| CN105707887A (en) * | 2016-03-03 | 2016-06-29 | 山东禹王制药有限公司 | Health care and weight loss chewable tablet and preparation method thereof |
| CN105747222A (en) * | 2016-03-17 | 2016-07-13 | 天津元恒德科技有限公司 | Composition having effects of lowering blood fat and reducing weight and application |
| CN105852094A (en) * | 2016-04-12 | 2016-08-17 | 陕西万维健康咨询服务有限公司 | Nutritional fruit and vegetable powder for reducing body weight, and production method thereof |
| CN106038704A (en) * | 2016-05-25 | 2016-10-26 | 吴敏浩 | Composition for inhibiting food digestion and absorption as well as preparation method and application of composition |
| CN106036342A (en) * | 2016-06-14 | 2016-10-26 | 安徽平唐微食疗科技有限公司 | Dietary supplement solid beverage suitable for diabetic population and preparation method of dietary supplement solid beverage |
| CN106306995A (en) * | 2016-08-19 | 2017-01-11 | 王评 | Slimming nutritional electuary and preparation method thereof |
| CN107183472A (en) * | 2017-07-25 | 2017-09-22 | 杭州诺利康健康管理有限公司 | One kind body shaping solid beverage |
| CN107912770A (en) * | 2017-10-09 | 2018-04-17 | 无比滴（广东）药业有限公司 | A kind of oral blocking agent for effectively suppressing food starch taken in excess |
| CN107637746A (en) * | 2017-10-20 | 2018-01-30 | 成都天美膳营养食品有限公司 | It is a kind of that there is fruity compound solid beverage that is anti-oxidant and improving metabolic function |
| CN108095068B (en) * | 2017-11-30 | 2020-10-27 | 北京东方红航天生物技术股份有限公司 | Food composition for weight management and method of use thereof |
| CN108095113A (en) * | 2017-12-22 | 2018-06-01 | 成都博创必成医药技术有限公司 | A kind of composition, preparation and its application with fat reducing blood sugar reducing function |
| CN108618134A (en) * | 2018-05-03 | 2018-10-09 | 江苏二十维生物科技有限公司 | A kind of healthy diet intervention product and its preparation method and application |
| CN108379359B (en) * | 2018-05-23 | 2021-05-11 | 南京中生生物科技有限公司 | L-arabinose composition with effects of reducing blood sugar and reducing fat and preparation method thereof |
| CN111493251A (en) * | 2019-01-30 | 2020-08-07 | 中粮营养健康研究院有限公司 | Solid beverage with synergistic weight-losing effect and preparation and eating methods thereof |
| CN109770361A (en) * | 2019-03-25 | 2019-05-21 | 杭州赛能医药科技有限公司 | A kind of navy bean diet fiber composition and its application |
| CN110150663A (en) * | 2019-05-31 | 2019-08-23 | 云南天保桦生物资源开发有限公司 | A kind of composition of complementary diets, chewable tablets and its preparation method and application |
| CN110250436A (en) * | 2019-06-13 | 2019-09-20 | 富民嘉友食品有限公司 | A kind of control energy mung bean cake |
| CN110558486A (en) * | 2019-09-30 | 2019-12-13 | 毕节市农业科学研究所 | Kidney bean instant food and preparation method thereof |
| CN114159404A (en) * | 2021-12-06 | 2022-03-11 | 无锡华康生物科技有限公司 | Microcapsule particle capable of adjusting body fat rate and preparation method thereof |
| CN116420875B (en) * | 2023-02-06 | 2024-03-15 | 黑龙江飞鹤乳业有限公司 | Nutritional composition for assisting blood lipid regulation and cardiovascular and cerebrovascular health |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001017369A1 (en) * | 1999-09-08 | 2001-03-15 | Med-Eq As | Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of 'fast sugars' |
| CN101683477A (en) * | 2008-09-25 | 2010-03-31 | 凌沛学 | Composition for fat-reducing |
| CN101810263A (en) * | 2009-12-16 | 2010-08-25 | 上海和兴源生物科技有限公司 | Compound biological sugar |
| CN103053903A (en) * | 2012-12-29 | 2013-04-24 | 北京中科邦尼国际科技有限责任公司 | Compound functional sugar with function of reducing food glycemic indexes |
-
2013
- 2013-09-17 CN CN201310426107.8A patent/CN103478738B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001017369A1 (en) * | 1999-09-08 | 2001-03-15 | Med-Eq As | Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of 'fast sugars' |
| CN101683477A (en) * | 2008-09-25 | 2010-03-31 | 凌沛学 | Composition for fat-reducing |
| CN101810263A (en) * | 2009-12-16 | 2010-08-25 | 上海和兴源生物科技有限公司 | Compound biological sugar |
| CN103053903A (en) * | 2012-12-29 | 2013-04-24 | 北京中科邦尼国际科技有限责任公司 | Compound functional sugar with function of reducing food glycemic indexes |
Non-Patent Citations (1)
| Title |
|---|
| A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): A review of clinical studies on weight loss and glycemic control;Marilyn L Barrett，et.al;《Barrett and Udani Nutrition Journal》;20111231;第10卷(第24期);第1-10页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103478738A (en) | 2014-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103478738B (en) | A kind of composition with fat-reducing body shaping and Weight management effect | |
| CN103340334B (en) | Freshwater fish feed and preparation method thereof | |
| CN104643250B (en) | It is a kind of can bidirectional modulation body weight improve inferior health solid beverage | |
| CN108272073A (en) | A kind of weight losing meal-replacing powder and preparation method thereof | |
| CN102524408A (en) | Nutritious soybean milk and preparation method thereof | |
| CN106942371A (en) | Black cereal Yoghourt and preparation method thereof | |
| CN101238893B (en) | High edible fibre chickpea nutritive powder and preparation and application thereof | |
| CN105249109A (en) | Preparation method of composite-probiotics-enriched plant enzymes drink capable of improving gastrointestinal function of child | |
| CN104799317B (en) | Sweet potato biscuit and preparation method thereof | |
| CN104799177A (en) | Sweet potato-based nutritious porridge and preparation method | |
| CN110236055A (en) | A kind of pectase beverage of protect liver and preparation method thereof | |
| CN111184214A (en) | Enzyme collagen coarse cereal, fruit and vegetable instant meal replacement porridge and making method thereof | |
| CN101496568A (en) | Mung bean or pea dietary fiber and method for producing the same | |
| CN106974263A (en) | A kind of energy lowering blood-fat and reducing weight, the preparation method of compound probiotic plant enzyme powder | |
| CN110279050A (en) | A kind of pectase beverage of detoxicating intestine and preparation method thereof | |
| CN105497106A (en) | Traditional Chinese medicine compound fermentation powder and preparation method thereof | |
| CN103343078B (en) | Production process of golden stichopus japonicus health-care yellow wine | |
| CN105851336A (en) | Dendrobium officinale tea and preparation method thereof | |
| CN102885364A (en) | Corn beverage and its preparation method | |
| CN106036269A (en) | Drink containing pumpkin enzymes and preparation method thereof | |
| CN107372947B (en) | Tea bag type blood sugar reducing tea and preparation method thereof | |
| CN104814372A (en) | Health guiling jelly based on sweet potatoes and preparation method of healthy guiling jelly | |
| CN110250411A (en) | A kind of Saussurea involucrata culture health nutrient meal | |
| CN110393246A (en) | A kind of oyster drink production method facilitating men's health | |
| CN107467654A (en) | One main laminaria sea cucumber composite extract and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |